Calderón-Larrañaga Amaia, Diaz Esperanza, Poblador-Plou Beatriz, Gimeno-Feliu Luis Andrés, Abad-Díez José María, Prados-Torres Alexandra
EpiChron Research Group on Chronic Diseases, Aragón Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Paseo Isabel La Católica 1-3, 50009 Zaragoza, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Carlos III Health Institute, C/ Sinesio Delgado 4, 28029 Madrid, Spain.
Department of Global Public Health and Primary Care, University of Bergen, Kalfarveien 31, NO-5020 Bergen, Norway; Norwegian Centre for Minority Health Research (NAKMI), Oslo University Hospital, PO box 4956, NO-0424 Oslo, Norway.
Int J Cardiol. 2016 Mar 15;207:310-6. doi: 10.1016/j.ijcard.2016.01.069. Epub 2016 Jan 11.
Multiple parameters influence adherence to drug treatment, including socio-economic, healthcare, condition, therapy, and patient-related factors. However, studies of the impact of patient-related factors, particularly regarding comorbid conditions, have produced conflicting results.
To analyse the association between mental and physical comorbidity and non-adherence to antihypertensive medication in patients attending primary care, after including a comprehensive range of chronic comorbidities and potential confounders.
Cross-sectional study of 113,397 adults with a diagnosis of hypertension in 2010 assigned to the public health service of a region in northeastern Spain. Pharmacy billing records were linked to data from electronic health records at individual level. Non-adherence was defined as an antihypertensive medication possession ratio (MPR) <80%. Multivariable logistic regression models were used to estimate the odds ratio for non-adherence. Potential predictors included mental and physical comorbidity, age, sex, blood pressure level, nationality, rurality, polypharmacy, and number of visits to the GP and to different specialties.
One fifth of the study population showed poor adherence levels. Female sex, younger age, foreign nationality, living in a rural area, low blood pressure levels, polypharmacy, and mental comorbidity were positively and significantly associated with non-adherence. Conversely, non-adherence was negatively and significantly associated with the presence of cardiovascular risk factors and higher annual rates of GP visits.
The majority of patient-related determinants identified here (e.g., the presence of mental comorbidity, polypharmacy, foreign nationality) underscores the need for a patient- rather than a disease-centred care approach, as well as adequate physician-patient communication.
多种因素会影响药物治疗的依从性,包括社会经济、医疗保健、病情、治疗以及患者相关因素。然而,关于患者相关因素影响的研究,尤其是合并症方面,结果相互矛盾。
在纳入一系列广泛的慢性合并症和潜在混杂因素后,分析基层医疗患者中精神和身体合并症与抗高血压药物治疗不依从之间的关联。
对2010年被诊断为高血压的113397名成年人进行横断面研究,这些患者隶属于西班牙东北部一个地区的公共卫生服务机构。药房计费记录与个人层面的电子健康记录数据相链接。不依从定义为抗高血压药物持有率(MPR)<80%。使用多变量逻辑回归模型估计不依从的比值比。潜在预测因素包括精神和身体合并症、年龄、性别、血压水平、国籍、农村地区、联合用药以及看全科医生和不同专科医生的次数。
五分之一的研究人群显示出较差的依从水平。女性、年轻、外国国籍、居住在农村地区、血压水平低、联合用药以及精神合并症与不依从呈正相关且具有显著意义。相反,不依从与心血管危险因素的存在以及较高的年度全科医生就诊率呈负相关且具有显著意义。
此处确定的大多数患者相关决定因素(例如精神合并症的存在、联合用药、外国国籍)强调了需要采取以患者而非疾病为中心的护理方法,以及充分的医患沟通。